IQV Collar Strategy
IQV (IQVIA Holdings Inc.), in the Healthcare sector, (Medical - Diagnostics & Research industry), listed on NYSE.
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services.
IQV (IQVIA Holdings Inc.) trades in the Healthcare sector, specifically Medical - Diagnostics & Research, with a market capitalization of approximately $28.77B, a trailing P/E of 20.96, a beta of 1.18 versus the broader market, a 52-week range of 134.65-247.05, average daily share volume of 1.8M, a public-listing history dating back to 2013, approximately 89K full-time employees. These structural characteristics shape how IQV stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.18 places IQV roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a collar on IQV?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
Current IQV snapshot
As of May 15, 2026, spot at $170.66, ATM IV 38.90%, IV rank 39.20%, expected move 11.15%. The collar on IQV below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this collar structure on IQV specifically: IV regime affects collar pricing on both sides; mid-range IQV IV at 38.90% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 11.15% (roughly $19.03 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IQV expiries trade a higher absolute premium for lower per-day decay. Position sizing on IQV should anchor to the underlying notional of $170.66 per share and to the trader's directional view on IQV stock.
IQV collar setup
The IQV collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IQV near $170.66, the first option leg uses a $180.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IQV chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IQV shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $170.66 | long |
| Sell 1 | Call | $180.00 | $4.80 |
| Buy 1 | Put | $160.00 | $3.60 |
IQV collar risk and reward
- Net Premium / Debit
- -$16,946.00
- Max Profit (per contract)
- $1,054.00
- Max Loss (per contract)
- -$946.00
- Breakeven(s)
- $169.46
- Risk / Reward Ratio
- 1.114
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
IQV collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on IQV. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$946.00 |
| $37.74 | -77.9% | -$946.00 |
| $75.48 | -55.8% | -$946.00 |
| $113.21 | -33.7% | -$946.00 |
| $150.94 | -11.6% | -$946.00 |
| $188.67 | +10.6% | +$1,054.00 |
| $226.41 | +32.7% | +$1,054.00 |
| $264.14 | +54.8% | +$1,054.00 |
| $301.87 | +76.9% | +$1,054.00 |
| $339.60 | +99.0% | +$1,054.00 |
When traders use collar on IQV
Collars on IQV hedge an existing long IQV stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
IQV thesis for this collar
The market-implied 1-standard-deviation range for IQV extends from approximately $151.63 on the downside to $189.69 on the upside. A IQV collar hedges an existing long IQV position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current IQV IV rank near 39.20% is mid-range against its 1-year distribution, so the IV signal is neutral; the collar thesis on IQV should anchor more to the directional view and the expected-move geometry. As a Healthcare name, IQV options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IQV-specific events.
IQV collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IQV positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IQV alongside the broader basket even when IQV-specific fundamentals are unchanged. Always rebuild the position from current IQV chain quotes before placing a trade.
Frequently asked questions
- What is a collar on IQV?
- A collar on IQV is the collar strategy applied to IQV (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With IQV stock trading near $170.66, the strikes shown on this page are snapped to the nearest listed IQV chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are IQV collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the IQV collar priced from the end-of-day chain at a 30-day expiry (ATM IV 38.90%), the computed maximum profit is $1,054.00 per contract and the computed maximum loss is -$946.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a IQV collar?
- The breakeven for the IQV collar priced on this page is roughly $169.46 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current IQV market-implied 1-standard-deviation expected move is approximately 11.15%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on IQV?
- Collars on IQV hedge an existing long IQV stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current IQV implied volatility affect this collar?
- IQV ATM IV is at 38.90% with IV rank near 39.20%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.